Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Study shows eating beans keeps off weight
The study looked at data taken from the National Nutrition and Health Examination Survey. The investigators found that adults who eat beans weigh an average of 6.6 pounds
The study looked at data taken from the National Nutrition and Health Examination Survey. The investigators found that adults who eat beans weigh an average of 6.6 pounds
The company also said in a presentation at the American Association of Cancer Research that combining the two drugs did not cause any observable increase in side effects.
Macular degeneration, a poorly treated condition, is the most common cause of vision loss in people over 60, affecting 20-25 million people worldwide. It is characterized by abnormal
According to the Israel-based generic drugmaker, total annual sales of the product are approximately $43 million. Teva also recently expanded its presence in the Chinese pharmaceutical market by
Atrial fibrillation, the most common cardiac arrhythmia, is an abnormal heart rhythm that affects the upper chambers of the heart, lowering the heart’s pumping capacity. The new drug
The study was conducted as a result of discussions with the FDA regarding potential expedited registration pathways for oral heparin. Previous studies have repeatedly demonstrated that Emisphere’s oral
MediciNova acquired a license to MN-246 from Mitsubishi Pharma Corporation for global markets, with the exception of Japan and other selected Asian countries. MN-246 is a novel, potent
The study was part of the company’s program to develop a DNA vaccine that could ultimately protect humans against emerging strains of avian flu that could cause a
The open label, single-arm, monotherapy registrational clinical trial is expected to enroll approximately 150 patients with unresectable stage III or stage IV metastatic melanoma who have progressed after
Based on the findings of this study, the company plans to file a market authorization application (MAA) with the European Agency for the Evaluation of Medicinal Products (EMEA)